This inventor holds 3 USPTO granted patents. Top assignee: University of Florida Research Foundation Inc.. Active years: 1998-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Columbia, MO (US) (1998)
- Tampa, FL (US) (1999 - 2002)
Company Filing History:
Years Active: 1998-2002
Title: Michael E Gruidl: Innovator in Entomopoxvirus Research
Introduction
Michael E Gruidl is a notable inventor based in Tampa, FL (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel expression systems using Entomopoxvirus. With a total of 3 patents to his name, Gruidl's work has implications for both insect and mammalian host cells.
Latest Patents
One of Gruidl's latest patents focuses on an Entomopoxvirus expression system. This invention pertains to novel Entomopoxvirus (EPV) polynucleotide sequences that are free from association with other viral sequences with which they are naturally associated. The patent includes recombinant polynucleotide vectors containing these sequences, recombinant viruses, and host cells infected with the recombinant viruses. Additionally, it outlines methods for using these innovations in the expression of heterologous proteins in both insect and mammalian host cells.
Career Highlights
Michael E Gruidl is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research. His work has garnered attention in the scientific community for its potential applications in biotechnology and medicine.
Collaborations
Gruidl has collaborated with notable colleagues, including Richard W Moyer and Richard L Hall. These partnerships have contributed to the development and refinement of his innovative research.
Conclusion
Michael E Gruidl stands out as a key figure in the field of biotechnology, particularly through his work on Entomopoxvirus expression systems. His contributions are paving the way for advancements in protein expression technologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
